It was recently reported that the calcium antagonist nifedipine suppresses aortic cholesterol accumulation in cholesterol-fed rabbits without reducing hypercholesterolemia. We extended this study on plasma lipoprotein levels and aortic influx of cholesteryl ester. We gave 40 mg per day of nifedipine orally to 17 rabbits fed a 2% cholesterol diet for 8 weeks. For the same period of time 15 control rabbits received placebo capsules and the same diet. During the study, total cholesterol, HDL, LDL, and VLDL cholesterol concentrations in plasma were not significantly different in the experimental and control animals. At the end of the study we found no difference in the two groups in accumulation of cholesterol in the intima media of the proximal thoracic aorta, the distal thoracic aorta, and the corresponding media layers. Furthermore, aortic influx of free cholesterol, cholesteryl ester, and albumin from plasma measured by radioactive tracers was not significantly affected by nifedipine.
H enry and Bentley recently reported
1 that the calcium antagonist nifedipine suppressed cholesterol accumulation in the thoracic aorta of cholesterol-fed rabbits without reducing hypercholesterolemia. Similar findings were also reported 23 for two other organic calcium antagonists, verapamil and diltiazem. Clinically, it is important to ascertain if a type of drug increasingly used in patients with ischemic heart disease can decrease atherogenesis. In these three studies the most significant reduction of atherogenesis was found in the rabbits that received nifedipine. 1 Our aim in the present study was to confirm this finding and to investigate in greater detail the effect of nifedipine on the cholesterol concentration and distribution in plasma lipoproteins and in the thoracic aorta. To elucidate the mechanism by which nifedipine reduces aortic cholesterol accumulation, we also determined the influx of free and esterified cholesterol and albumin from plasma into the aortic intima media using radioactive tracers. 4 '
Methods
Thirty-two male, white, inbred rabbits of the Danish Country strain from Statens Serum Institut in Copenhagen, weighing 2.5 to 2.9 kg, were pairmatched into two groups with the same mean cholesterol level in plasma and the same mean body weight. The rabbits were housed individually under controlled environmental conditions. For a period of 8 weeks each rabbit was daily fed 100 g of standard rabbit pellets (Boserup, Faxe, Denmark) containing 2 g of cholesterol. Water was given ad libitum. To 17 of the rabbits, nifedipine was force-fed, two 10 mg capsules in the morning and two in the afternoon (40 mg/day); the remaining animals received two placebo capsules at the same feeding hours. Sex, body weight, cholesterol content of diet, drug dosage, and duration of the experiment were the same as those used by Henry and Bentley. 1 Blood samples were drawn from an ear vein at Weeks 1, 3, 6, and 8. Plasma aliquots from the samples obtained at Weeks 1, 3, and 6 were adjusted to a density of 1.019 and 1.063 and centrifuged at 4 °C at 1.58 x 10 8 g/min in a 40.3 Beckman Rotor. The cholesterol content in the aliquots of whole plasma and in the various ultracentrifuged fractions were determined by the Lieberman-Burchard reaction after extraction and saponification of the lipids. 4 Blood samples for nifedipine analysis were taken 1 hour and 12 to 16 hours after the dose of nifedipine in Weeks 1 and 6.
Plasma labeled in vivo with 3 H and 14 C-cholesterol and serum proteins labeled in vivo with 3 H-leucine were injected intravenously into 24 rabbits 4 to 6 hours before sacrifice. The doubly labeled lipoproteins were obtained from four donor rabbits, each intravenously injected with 4.0 mCi of 1a,2a(n)-3 Hcholesterol (Amersham) in alcoholic saline, and at the same time fed 0.4 mCi of 4-14 C-cholesterol (Amersham). After 16 to 18 hours, they were anesthetized with intravenously injected pentobarbital (approximately 50 mg/kg body weight) and exsanguinated. 4 The cholesterol-labeled serum that was intravenously injected into 12 of the placebotreated rabbits originated from two other rabbits in the placebo group. The 3 H-leucine-labeled plasma preparation was obtained from two untreated normocholesterolemic rabbits, each of which had been intravenously injected with 25 mCi L^.S^H-leucine (Amersham) 12 hours before exsanguination. 5 The plasma was dialyzed with five changes of 100 volumes of isotonic saline, at which time no radioactivity ( 3 H-leucine) was present in the dialysate. Fibrin was removed by centrifugation. The preparations labeled in vivo were filtered through 0.22 yu.m millipore filters (Millex from GS Millipore S.A., Molsheim, France) immediately before use.
Blood samples were drawn at regular intervals from the time the labeled preparations were injected until the rabbits were killed by intravenous injection of a 5% pentobarbital solution. The thoracic portion of the aorta was dissected free and the adventitia was carefully removed under running saline. 4 The aorta was opened longitudinally and the surface was rinsed again with saline. The vessel was fixed with pins on a corkboard, the area was outlined, and the tissue was divided into proximal and distal parts at the level of the first intercostal arteries. From each of these parts, the inner layer containing the intima and part of the media was stripped from the underlying outer media, and all four parts were weighed. Within 30 minutes the tissues were stored at 20 °C until analysis.
The radioactivity in amino acids, in free and esterified cholesterol, and in the proteins of each plasma sample was determined. The plasma samples were extracted with chloroform/methanol 1:1 (vol/vol). The precipitate, which constituted the protein fraction, was packed by centrifugation and washed twice with the solvent. To the combined washes, we added one-half a volume of chloroform and 20% of the final volume as water. The upper phase was removed, washed twice with chloroform, and dried in a counting vial before measurement of its content of 3 H, which was due to labeled amino acids. Aliquots of the chloroform phase were used to determine the radioactivity in the total cholesterol and to separate the free and esterified cholesterol by thin-layer chromatography for subsequent measurements of mass and radioactivity. This procedure and its ability to separate amino acids, proteins, and cholesterol has previously been described in detail. 5 ' 7 The aortic tissue was minced and the lipids were extracted during a period of 24 hours. Proteins, lipids, and amino acids were separated. 5 ' 7 The mass of free cholesterol before and after saponification was determined by thin-layer chromatography using a micromethod. 8 The difference between the two values was esterified cholesterol. Free and esterified cholesterol were determined in the intima-media samples, but only total cholesterol was determined in the media samples. The amount of protein in tissue and serum was determined by the method of Lowry et al. 9 following extraction of the lipids and digestion of the residue for 24 hours with 5 M NaOH. The reference serum of animal origin (Seronorm, Nyegaard and Company, Oslo, Norway) was treated in a similar way and used to calibrate the protein determinations.
Influx Calculations
The influx of cholesterol and proteins from plasma into the intima-media layer of the proximal aorta was calculated by the "sink" or integral method, in which the amount of radioactivity in the tissue is divided by the area below the plasma specific activity versus the time curve of the corresponding component. 45 To correct for the hydrolysis of esterified cholesterol and for the esterification of free cholesterol in the arterial tissue after uptake of the tracers, a set of linear equations was used.
In these equations, ° = 14 C and * = 3 H; t(TC) is the total cholesterol in the intima-media layer; K E and Kp represent the influx of esterified and free cholesterol, respectively; T is the time interval from dose injection until tissue removal; s(E) and s(F) are the mean specific activities in the plasma of esterified and free cholesterol, respectively. The development of and assumptions for these equations are described in detail elsewhere. 10 The unidirectional permeability coefficients for albumin and esterified cholesterol were calculated by dividing the influx of the constituent by the plasma concentration of that constituent.
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Results
The rabbits in the nifedipine group tolerated the drug without visible side effects, and the mean increase in body weight was the same in the two groups: 0.31 ± 0.04 kg (x ± SE) in the nifedipine group and 0.28 ± 0.03 kg in the placebo group. Nifedipine obviously had an unpleasant taste since it usually required about 5 minutes to feed the two nifedipine capsules and only about 1 minute to feed the placebo capsules. The 1-hour postabsorptive level of nifedipine in plasma was 0.9 ± 0.1 (x ± SE, n = 16) with a range of 0.3 to 2.0 /*g/ml, but less than 0.15 /ng/ml at 12 to 16 hours after the drug dose. During the experimental period there was no significant difference between the plasma cholesterol concentrations in the two groups (Figure 1 , left panel). VLDL, LDL, and HDL cholesterol concentrations were not significantly affected by nifedipine after 1,3, and 6 weeks (Figure 2 ).
In the placebo group the total thoracic aorta had an endothelial surface area of 11.4 ± 0.5 cm 2 , a wet weight of 0.54 ± 0.02 g, and a protein concentration of 96 ± 3mg x g -1 (x ± SE, n = 17). The proximal thoracic aorta had a surface area of 4.1 ± 0.2 cm 2 . Similar values were found for the thoracic aorta in the nifedipine group.
The concentrations of free and esterified cholesterol in the intima-media preparations from proximal and distal parts of the thoracic aorta and the total cholesterol in the media did not differ significantly between the two groups (Table 1) .
A bolus of homologous in vivo labeled plasma was injected into 24 animals, 12 from the experimental group and 12 from the control group. Figure 3 shows typical curves of the specific activity in plasma of free cholesterol, of esterified cholesterol, and of protein from the time of injection until the aorta was removed. The ratio between the specific activity of free cholesterol and the specific activity of esterified cholesterol was much higher for 3 H than for 14 C during the entire period. This is a condition for the solution of Equations (1) and (2). Influx values were calculated only for the intima-media layer of the proximal thoracic aorta. Similar values from the distal part of the vessel were not calculated since the tissue contained insignificant amounts of radioactivity. The influx of free and esterified cholesterol was not significantly affected by nifedipine ( Table 2 ).
The elution profile of plasma labeled in vivo with 3 H-leucine was determined on an ACA-44 Ultrogel (LKB, Bromma Sweden). The column was 1 x 100 cm, and the elution buffer was 5 mM Tris-HCI (pH 7.4), 150 mM NaCI, and 0.5 mM EDTA. The labeled constituents appeared in a single peak with a molecular diameter of approximately 7 nm. This corresponds to the size of albumin.
The rabbits that had been injected with the labeled protein preparation had no detectable amounts of radioactivity in the amino acids in the plasma and in the aortic tissue apart from that incorporated into the proteins. The influx of albumin into the intima-media layer of the proximal thoracic aorta was not affected Figure 3 . The specific activities in plasma of proteins, esterified cholesterol (EC), and free cholesterol (FC) from the time of injection until the aorta was removed. The rabbit was intravenously injected with serum obtained from a donor rabbit which was fed and intravenously injected with suspensions of 14 C-and 3 H-cholesterol, respectively. At the same time, the recipient rabbit was intravenously injected with serum protein biosynthetically labeled with 3 Hleucine. The mean values of the specific activities were used for the influx calculations. by nifedipine. Also, the permeability coefficients for cholesteryl ester and the permeability coefficients for the albumin fraction were unaffected by nifedipine (Table 2 ).
Discussion
Our study was designed to reproduce the same experimental conditions as those described by Henry and Bentley.
1 The mean plasma cholesterol levels after 8 weeks were very similar in the two studies. However, Henry and Bentley only investigated plasma cholesterol levels when the animals were killed after 8 weeks. There is a possibility that the plasma cholesterol levels were different in the experimental and placebo animals during their study, which would explain the differences in aortic cholesterol deposition. However, we found no difference in the plasma cholesterol levels of the two groups during our study (Figure 1, left panel) .
The distributions of cholesterol among the plasma lipoprotein fractions VLDL, LDL, and HDL may be as important for the accumulation of cholesterol in the arterial wall of rabbits as it is in humans, where LDL is considered atherogenic and HDL, antiatherogenic. However, the cholesterol distribution between VLDL, LDL, and HDL lipoprotein in the hypercholesterolemic rabbits was not significantly influenced by nifedipine (Figure 2) . A similar lack of effect on concentration of plasma lipoproteins was found in cholesterol-fed rabbits treated with verapamil. 3 Esterified cholesterol in the intima and inner media is considered a sensitive marker of atherosclerotic lesions in rabbits, since it only occurs in the aortic tissue after the rabbits have been hypercholesterolemic for several weeks. 8 Neither in the intima-media layer of the proximal thoracic aorta, a region with high cholesterol concentration, nor in the intima-media layer of the distal thoracic aorta, a region with low cholesterol concentration, did nifedipine influence the accumulation of esterified and free cholesterol (Table 1) .
To compare our results with those of Henry and Bentley, we calculated the total cholesterol concentration in the entire thoracic aorta for each animal (Figure 1, right panel) . The mean values were very similar in the two groups but were twice as high as those reported by Henry and Bentley.
We have not been able to find other studies in which rabbits were fed a cholesterol-enriched diet for 8 weeks and in which the cholesterol content in the aorta was expressed per gram of protein. Table 3 shows that the aortic tissue concentration of cholesterol per gram of wet weight in the present study is among the lowest values when compared with other similar studies.
12 -15 Apparently Henry and Bentley used rabbits with an extraordinary resistance to the atherogenic effect of hypercholesterolemia. If such resistance is important for the antiatherogenic action of nifedipine, the distal part of the thoracic aorta, The number of rabbits is given in parentheses in the second column under aortic cholesterol, and the percentage of cholesterol in the diet is given in parentheses in the third column under duration. which is much more resistant than the proximal part, should respond to the treatment with nifedipine. This was not the case in our study (Table 1) . The influx and permeability coefficients of cholesterol and albumin in our study are about the same as those observed in other studies. 4 -5 Nifedipine did not change the mean values significantly ( Table 2 ). The cholesterol content in the intima-media layer of the proximal part of the thoracic aorta and the cholesteryl ester influx into that tissue were highly correlated, as was also observed in a recently published study by Stein et al. 15 The influx of cholesteryl ester into the intimamedia of the thoracic aorta in hypercholesterolemic rabbits has previously been shown to occur as an influx of plasma lipoproteins. 5 In that study, high permeability coefficients for plasma lipoproteins were associated with high permeability coefficients for albumin in four rabbits in which the two permeability coefficients were measured concomitantly. The same relationship between the two simultaneously measured permeability coefficients was demonstrated in the present study of 24 rabbits (Figure 4) . In future studies of the mechanism behind a putative antiatherogenic action of a drug, the rather simple measurement of arterial protein influx can thus be used to estimate the arterial lipoprotein influx, which can be measured now only by a much more elaborate procedure.
From the results of the present experiment, we conclude that nifedipine does not influence the cholesterol concentrations in plasma lipoproteins or the influx and accumulation of cholesterol and albumin in the thoracic aorta of cholesterol-fed rabbits.
This conclusion is in accordance with a preliminary report 16 about the effect on cholesterol-fed rabbits of a smaller dose of nifedipine than that used by Henry and Bentley.
The two other organic calcium antagonists, verapamil and diltiazem, which have been found to reduce the extent of atherosclerotic lesions in cholesterolfed rabbits without reducing hypercholesterolemia, differ from nifedipine in structure and in various pharmacological effects. Verapamil is a papaverine derivative, nifedipine is a dihydropyridine derivative, and diltiazem is a benzothiazepine derivative. For example, in contrast to verapamil and diltiazem, nifedipine does not exhibit nonspecific sympathetic antagonism. The clinical electrophysiologic property of nifedipine is also markedly different from those of verapamil and diltiazem. 17 '
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It was previously suggested 1 -3 that the antiatherogenic effect of the various calcium-antagonists was due to their effect in reducing calcium influx into the cells of the arterial wall. With the present study in mind, the mechanism of the antiatherogenic action of verapamil and diltiazem may be associated with an effect on cellular functions which is more affected by these drugs than by nifedipine.
